nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—Crohn's disease	0.289	1	CbGaD
Phenylbutazone—PTGS2—Balsalazide—Crohn's disease	0.133	0.209	CbGbCtD
Phenylbutazone—PTGS1—Balsalazide—Crohn's disease	0.112	0.176	CbGbCtD
Phenylbutazone—PTGS2—Mesalazine—Crohn's disease	0.106	0.167	CbGbCtD
Phenylbutazone—PTGS1—Mesalazine—Crohn's disease	0.0896	0.141	CbGbCtD
Phenylbutazone—SLC22A8—Mercaptopurine—Crohn's disease	0.0773	0.121	CbGbCtD
Phenylbutazone—PTGS2—Sulfasalazine—Crohn's disease	0.0593	0.0932	CbGbCtD
Phenylbutazone—PTGS1—Sulfasalazine—Crohn's disease	0.0501	0.0787	CbGbCtD
Phenylbutazone—CYP3A4—Prednisone—Crohn's disease	0.00937	0.0147	CbGbCtD
Phenylbutazone—PTGIS—gall bladder—Crohn's disease	0.00425	0.263	CbGeAlD
Phenylbutazone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00367	0.0642	CbGpPWpGaD
Phenylbutazone—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00367	0.0642	CbGpPWpGaD
Phenylbutazone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.0028	0.049	CbGpPWpGaD
Phenylbutazone—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.0028	0.049	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinamide salvaging—PTGS2—Crohn's disease	0.00259	0.0453	CbGpPWpGaD
Phenylbutazone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00233	0.0409	CbGpPWpGaD
Phenylbutazone—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00233	0.0409	CbGpPWpGaD
Phenylbutazone—PTGIS—smooth muscle tissue—Crohn's disease	0.00212	0.131	CbGeAlD
Phenylbutazone—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.00203	0.0355	CbGpPWpGaD
Phenylbutazone—PTGIS—mammalian vulva—Crohn's disease	0.00191	0.118	CbGeAlD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.00164	0.0286	CbGpPWpGaD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—GPX4—Crohn's disease	0.00153	0.0267	CbGpPWpGaD
Phenylbutazone—PTGIS—Nicotinate metabolism—PTGS2—Crohn's disease	0.00138	0.0241	CbGpPWpGaD
Phenylbutazone—PTGIS—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.00114	0.0199	CbGpPWpGaD
Phenylbutazone—PTGIS—lymph node—Crohn's disease	0.000955	0.059	CbGeAlD
Phenylbutazone—SLC22A11—digestive system—Crohn's disease	0.000936	0.0579	CbGeAlD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000928	0.0162	CbGpPWpGaD
Phenylbutazone—PTGS2—gall bladder—Crohn's disease	0.000761	0.047	CbGeAlD
Phenylbutazone—PTGIS—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000738	0.0129	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000735	0.0129	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000735	0.0129	CbGpPWpGaD
Phenylbutazone—PTGS2—mouth—Crohn's disease	0.000677	0.0418	CbGeAlD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000656	0.0115	CbGpPWpGaD
Phenylbutazone—PTGIS—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.000618	0.0108	CbGpPWpGaD
Phenylbutazone—PTGIS—Bile acid and bile salt metabolism—ALB—Crohn's disease	0.00061	0.0107	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.0006	0.0105	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.00056	0.00981	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.00056	0.00981	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000503	0.0088	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000469	0.00821	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000468	0.00818	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000468	0.00818	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000458	0.00801	CbGpPWpGaD
Phenylbutazone—PTGS1—epithelium—Crohn's disease	0.000412	0.0255	CbGeAlD
Phenylbutazone—PTGIS—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.00041	0.00718	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.000408	0.00714	CbGpPWpGaD
Phenylbutazone—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000399	0.00699	CbGpPWpGaD
Phenylbutazone—PTGS1—smooth muscle tissue—Crohn's disease	0.000397	0.0245	CbGeAlD
Phenylbutazone—PTGS2—epithelium—Crohn's disease	0.000394	0.0243	CbGeAlD
Phenylbutazone—PTGS1—skin of body—Crohn's disease	0.000392	0.0242	CbGeAlD
Phenylbutazone—PTGS2—smooth muscle tissue—Crohn's disease	0.000379	0.0234	CbGeAlD
Phenylbutazone—PTGIS—Adipogenesis—SOCS1—Crohn's disease	0.000378	0.00661	CbGpPWpGaD
Phenylbutazone—PTGS2—skin of body—Crohn's disease	0.000374	0.0231	CbGeAlD
Phenylbutazone—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000372	0.00652	CbGpPWpGaD
Phenylbutazone—PTGS1—mammalian vulva—Crohn's disease	0.000357	0.0221	CbGeAlD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000352	0.00615	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000349	0.00612	CbGpPWpGaD
Phenylbutazone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000349	0.00611	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000349	0.00611	CbGpPWpGaD
Phenylbutazone—CYP2C9—digestive system—Crohn's disease	0.000343	0.0212	CbGeAlD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000334	0.00584	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000334	0.00584	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—SMAD3—Crohn's disease	0.000326	0.00571	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000324	0.00567	CbGpPWpGaD
Phenylbutazone—PTGS1—digestive system—Crohn's disease	0.000313	0.0194	CbGeAlD
Phenylbutazone—Diphenhydramine—SLC22A5—Crohn's disease	0.000303	0.28	CrCbGaD
Phenylbutazone—PTGS2—lymphoid tissue—Crohn's disease	0.000303	0.0187	CbGeAlD
Phenylbutazone—PTGS2—digestive system—Crohn's disease	0.000299	0.0185	CbGeAlD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000299	0.00523	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000298	0.00522	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000291	0.0051	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000274	0.00479	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000265	0.00464	CbGpPWpGaD
Phenylbutazone—PTGIS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—Crohn's disease	0.000264	0.00461	CbGpPWpGaD
Phenylbutazone—Oxaprozin—PTGS2—Crohn's disease	0.000262	0.242	CrCbGaD
Phenylbutazone—CYP3A4—digestive system—Crohn's disease	0.000262	0.0162	CbGeAlD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000255	0.00446	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000255	0.00446	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000247	0.00432	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	0.000245	0.00428	CbGpPWpGaD
Phenylbutazone—Fosphenytoin—ALB—Crohn's disease	0.000243	0.225	CrCbGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000237	0.00415	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000235	0.00412	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000233	0.00408	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	0.000228	0.00398	CbGpPWpGaD
Phenylbutazone—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.000227	0.00397	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	0.000226	0.00396	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000218	0.00382	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000212	0.00372	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000212	0.00372	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000211	0.00369	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000208	0.00364	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000191	0.00334	CbGpPWpGaD
Phenylbutazone—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.00019	0.00332	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	0.000188	0.00328	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	0.000185	0.00323	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	0.000181	0.00316	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000179	0.00314	CbGpPWpGaD
Phenylbutazone—PTGS1—lymph node—Crohn's disease	0.000179	0.0111	CbGeAlD
Phenylbutazone—PTGS2—lymph node—Crohn's disease	0.000171	0.0106	CbGeAlD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00017	0.00297	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00017	0.00297	CbGpPWpGaD
Phenylbutazone—Phenprocoumon—ALB—Crohn's disease	0.000167	0.154	CrCbGaD
Phenylbutazone—PTGIS—Disease—RSPO3—Crohn's disease	0.000163	0.00286	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	0.000162	0.00283	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000159	0.00278	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	0.000158	0.00277	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PLA2G4F—Crohn's disease	0.000157	0.00274	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SEL1L—Crohn's disease	0.000155	0.00271	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.00015	0.00262	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—STAT3—Crohn's disease	0.000149	0.00261	CbGpPWpGaD
Phenylbutazone—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	0.000149	0.00261	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	0.000147	0.00257	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	0.000141	0.00247	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—LTF—Crohn's disease	0.000139	0.00243	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—MTMR3—Crohn's disease	0.000133	0.00233	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000132	0.00232	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000129	0.00226	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000129	0.00226	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—TNF—Crohn's disease	0.000129	0.00226	CbGpPWpGaD
Phenylbutazone—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000126	0.00221	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	0.00012	0.00209	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.00012	0.00209	CbGpPWpGaD
Phenylbutazone—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	0.000118	0.00207	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—GCKR—Crohn's disease	0.000112	0.00196	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	0.00011	0.00193	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000108	0.00189	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000108	0.00189	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000108	0.00189	CbGpPWpGaD
Phenylbutazone—Phenytoin—ALB—Crohn's disease	0.000107	0.0992	CrCbGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000106	0.00185	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	0.000104	0.00183	CbGpPWpGaD
Phenylbutazone—PTGIS—Adipogenesis—IL6—Crohn's disease	0.000104	0.00182	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—FADS1—Crohn's disease	0.000104	0.00182	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC11A1—Crohn's disease	9.9e-05	0.00173	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GPX4—Crohn's disease	9.71e-05	0.0017	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	9.71e-05	0.0017	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	9.5e-05	0.00166	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—GCKR—Crohn's disease	9.38e-05	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	9.19e-05	0.00161	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	9.17e-05	0.00161	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	9.12e-05	0.0016	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—GPX4—Crohn's disease	9.05e-05	0.00158	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	8.73e-05	0.00153	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.58e-05	0.0015	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—RBX1—Crohn's disease	8.49e-05	0.00149	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HSPA1B—Crohn's disease	8.49e-05	0.00149	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	8.37e-05	0.00147	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	8.06e-05	0.00141	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	8.03e-05	0.0014	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	7.74e-05	0.00135	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	7.61e-05	0.00133	CbGpPWpGaD
Phenylbutazone—SLC22A11—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.49e-05	0.00131	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	7.47e-05	0.00131	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—UBE2D1—Crohn's disease	7.45e-05	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.3e-05	0.00128	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	7.28e-05	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	7.23e-05	0.00126	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	7.2e-05	0.00126	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	7.16e-05	0.00125	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	6.91e-05	0.00121	CbGpPWpGaD
Phenylbutazone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	6.76e-05	0.00118	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	6.73e-05	0.00118	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	6.71e-05	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	6.71e-05	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	6.66e-05	0.00117	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	6.65e-05	0.00116	CbGpPWpGaD
Phenylbutazone—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	6.63e-05	0.00116	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	5.97e-05	0.00104	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	5.93e-05	0.00104	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.87e-05	0.00103	CbGpPWpGaD
Phenylbutazone—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.71e-05	0.000999	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.68e-05	0.000995	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	5.68e-05	0.000995	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	5.42e-05	0.000948	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SMAD3—Crohn's disease	5.33e-05	0.000932	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.32e-05	0.000932	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	5.26e-05	0.00092	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	4.89e-05	0.000855	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	4.83e-05	0.000846	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PLA2G4F—Crohn's disease	4.81e-05	0.000843	CbGpPWpGaD
Phenylbutazone—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	4.76e-05	0.000834	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	4.69e-05	0.00082	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	4.37e-05	0.000765	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	4.3e-05	0.000753	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—MTMR3—Crohn's disease	4.09e-05	0.000716	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RSPO3—Crohn's disease	3.99e-05	0.000698	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PLA2G4F—Crohn's disease	3.82e-05	0.000669	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ALB—Crohn's disease	3.8e-05	0.000666	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SEL1L—Crohn's disease	3.78e-05	0.000662	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	3.76e-05	0.000659	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.52e-05	0.000617	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TYK2—Crohn's disease	3.47e-05	0.000608	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	3.47e-05	0.000608	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	3.4e-05	0.000595	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—LTF—Crohn's disease	3.39e-05	0.000594	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—JAK2—Crohn's disease	3.31e-05	0.00058	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—MTMR3—Crohn's disease	3.25e-05	0.000569	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FADS1—Crohn's disease	3.19e-05	0.000558	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CD4—Crohn's disease	3.14e-05	0.00055	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTGS2—Crohn's disease	3.12e-05	0.000546	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ALB—Crohn's disease	2.99e-05	0.000523	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GPX4—Crohn's disease	2.99e-05	0.000523	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	2.9e-05	0.000508	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—GCKR—Crohn's disease	2.88e-05	0.000505	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	2.75e-05	0.00048	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—GCKR—Crohn's disease	2.73e-05	0.000478	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTGS2—Crohn's disease	2.61e-05	0.000457	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FADS1—Crohn's disease	2.53e-05	0.000443	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	2.53e-05	0.000443	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—Crohn's disease	2.43e-05	0.000426	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	2.42e-05	0.000424	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC11A1—Crohn's disease	2.42e-05	0.000423	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GPX4—Crohn's disease	2.37e-05	0.000415	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.31e-05	0.000405	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—GCKR—Crohn's disease	2.29e-05	0.000401	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—MTMR3—Crohn's disease	2.15e-05	0.000377	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—RBX1—Crohn's disease	2.07e-05	0.000363	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HSPA1B—Crohn's disease	2.07e-05	0.000363	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	2.06e-05	0.000361	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—UBE2D1—Crohn's disease	1.82e-05	0.000318	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.8e-05	0.000316	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—Crohn's disease	1.7e-05	0.000297	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FADS1—Crohn's disease	1.68e-05	0.000293	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	1.67e-05	0.000292	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.64e-05	0.000286	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GPX4—Crohn's disease	1.57e-05	0.000275	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—GCKR—Crohn's disease	1.52e-05	0.000265	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.42e-05	0.000248	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SMAD3—Crohn's disease	1.3e-05	0.000227	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FADS1—Crohn's disease	1.11e-05	0.000193	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.08e-05	0.00019	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GPX4—Crohn's disease	1.04e-05	0.000181	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—GCKR—Crohn's disease	1e-05	0.000175	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	9.48e-06	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ALB—Crohn's disease	9.18e-06	0.000161	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TYK2—Crohn's disease	8.48e-06	0.000148	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—JAK2—Crohn's disease	8.09e-06	0.000142	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTGS2—Crohn's disease	8.03e-06	0.000141	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CD4—Crohn's disease	7.67e-06	0.000134	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ALB—Crohn's disease	7.29e-06	0.000128	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—Crohn's disease	5.94e-06	0.000104	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ALB—Crohn's disease	4.83e-06	8.44e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTGS2—Crohn's disease	4.22e-06	7.39e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—Crohn's disease	4.15e-06	7.26e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ALB—Crohn's disease	3.18e-06	5.57e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTGS2—Crohn's disease	2.78e-06	4.87e-05	CbGpPWpGaD
